SUREXEVO
LIVE

Serial Number

79446428

Owner

SANSURE BIOTECH INC.

Attorney

Utsav Mukherjee

Filing Date

Dec 17, 2025

Add to watchlist:

No watchlists yet
View on USPTO

SUREXEVO Trademark

Serial Number: 79446428

SUREXEVO is a trademark filed by SANSURE BIOTECH INC. on December 17, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

SANSURE BIOTECH INC. (2 trademarks)

No. 680, Lusong Road,

Entity Type: 99

Trademark Details

Filing Date

December 17, 2025

Registration Date

Not Registered

Published for Opposition

August 11, 2026

Goods & Services

Testing apparatus for medical purposes, namely, for detecting and measuring antibody levels; medical apparatus and instruments, namely, medical diagnostic apparatus for nucleic acid and genetic testing; apparatus for use in medical analysis in the nature of hematology analyzers; apparatus for blood analysis; apparatus for DNA and RNA testing for medical purposes; body composition analyzers for medical use; medical diagnostic apparatus for the detection of abnormal prion protein; diagnostic apparatus for medical purposes for detecting biomarkers; diagnostic apparatus for medical purposes for detecting viruses; immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels; genetic testing apparatus for medical purposes; analyzers for bacterial identification for medical purposes.

Chemical reagents for medical or veterinary purposes; biological preparations for use in cell cultures for medical purposes; diagnostic preparations for medical purposes; diagnostic reagents for medical purposes; diagnostic biomarker reagents for medical purposes; genetic identity tests comprised of reagents for medical purposes; reagents for medical purposes; diagnostic preparations for medical and veterinary purposes; reagents for use in medical genetic testing; pharmaceutical preparations for the treatment and prevention of viral and infectious diseases; chemical preparations for medical purposes, namely, for the treatment and prevention of viral and infectious diseases; enzyme preparations for medical purposes; immunoassay reagents for medical purposes.

Data processing apparatus; downloadable computer operating programs; recorded computer operating programs; recorded computer software for detecting genetic sequences; recorded computer software for detecting and measuring antibody levels; downloadable computer software for detecting genetic sequences; downloadable computer software for detecting and measuring antibody levels; recorded computer programs for detecting genetic sequences; recorded computer programs for detecting and measuring antibody levels; downloadable computer programs for detecting genetic sequences;downloadable computer programs for detecting and measuring antibody levels; downloadable computer software for database management; recorded computer software for database management; DNA chips; DNA microarrays for laboratory use; laboratory devices for detecting genetic sequences; gene amplifiers, namely, gene amplification apparatus for scientific research in laboratories; apparatus and instruments for physics for extracting nucleic acid for laboratory use; medical laboratory research instruments for detecting pathogens; chemistry apparatus and instruments, namely, beakers, test tubes, and laboratory pipettes; chromatography apparatus for laboratory use; diagnostic apparatus for research laboratory use for DNA analysis; devices for analyzing genome information, namely, laboratory devices for detecting genetic sequences; nucleic acid sequencers for scientific purposes; biochips for research or scientific purposes; biochip sensors for scientific use

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 15, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 14, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 14, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 14, 2026 TROA
REFUSAL PROCESSED BY IB
Jun 18, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 4, 2026 RFCS
REFUSAL PROCESSED BY MPU
Jun 4, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 23, 2026 RFCR
NON-FINAL ACTION WRITTEN
Apr 22, 2026 CNRT
ASSIGNED TO EXAMINER
Apr 20, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 27, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 27, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 26, 2026 REPR